On the contrary, it was shown that low SEMA3B expression associated with poorer OS in gliomas, but when associated with expression of two other genes, osteonectin/SPARC and doublecortex/doublecortin (Rich et al, 2005). The gene discussed is SEMA3B; the disease is central nervous system cancer.